title: Lymphadenopathy in patients with multiple sclerosis undergoing treatment with glatiramer acetate.
authors.forename: A
authors.initials: A
authors.lastname: Windhagen
authors.forename: S
authors.initials: S
authors.lastname: Maniak
authors.forename: S
authors.initials: S
authors.lastname: Marckmann
authors.forename: R B
authors.initials: RB
authors.lastname: Lindert
authors.forename: F
authors.initials: F
authors.lastname: Heidenreich
authors.forename: R
authors.initials: R
authors.lastname: Blasczyk
mesh_terms: D000068717:Glatiramer Acetate; D006801:Humans; D008206:Lymphatic Diseases / Q000209:etiology*; D009103:Multiple Sclerosis / Q000150:complications* / Q000188:drug therapy*; D010455:Peptides / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D010455:Peptides; D000068717:Glatiramer Acetate